Literature DB >> 21956378

Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness.

Katherine A MacLean1, Matthew W Johnson, Roland R Griffiths.   

Abstract

A large body of evidence, including longitudinal analyses of personality change, suggests that core personality traits are predominantly stable after age 30. To our knowledge, no study has demonstrated changes in personality in healthy adults after an experimentally manipulated discrete event. Intriguingly, double-blind controlled studies have shown that the classic hallucinogen psilocybin occasions personally and spiritually significant mystical experiences that predict long-term changes in behaviors, attitudes and values. In the present report we assessed the effect of psilocybin on changes in the five broad domains of personality - Neuroticism, Extroversion, Openness, Agreeableness, and Conscientiousness. Consistent with participant claims of hallucinogen-occasioned increases in aesthetic appreciation, imagination, and creativity, we found significant increases in Openness following a high-dose psilocybin session. In participants who had mystical experiences during their psilocybin session, Openness remained significantly higher than baseline more than 1 year after the session. The findings suggest a specific role for psilocybin and mystical-type experiences in adult personality change.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21956378      PMCID: PMC3537171          DOI: 10.1177/0269881111420188

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  34 in total

1.  Modeling intraindividual change in personality traits: findings from the normative aging study.

Authors:  Daniel K Mroczek; Avron Spiro
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2003-05       Impact factor: 4.077

2.  Comparison of psilocin with psilocybin, mescaline and LSD-25.

Authors:  A B WOLBACH; E J MINER; H ISBELL
Journal:  Psychopharmacologia       Date:  1962

Review 3.  The neurobiology of psychedelic drugs: implications for the treatment of mood disorders.

Authors:  Franz X Vollenweider; Michael Kometer
Journal:  Nat Rev Neurosci       Date:  2010-08-18       Impact factor: 34.870

Review 4.  The standardized psychometric assessment of altered states of consciousness (ASCs) in humans.

Authors:  A Dittrich
Journal:  Pharmacopsychiatry       Date:  1998-07       Impact factor: 5.788

5.  LSD revisited. A ten-year follow-up of medical LSD use.

Authors:  W H McGlothlin; D O Arnold
Journal:  Arch Gen Psychiatry       Date:  1971-01

6.  Human psychopharmacology of hoasca, a plant hallucinogen used in ritual context in Brazil.

Authors:  C S Grob; D J McKenna; J C Callaway; G S Brito; E S Neves; G Oberlaender; O L Saide; E Labigalini; C Tacla; C T Miranda; R J Strassman; K B Boone
Journal:  J Nerv Ment Dis       Date:  1996-02       Impact factor: 2.254

7.  Sources of human psychological differences: the Minnesota Study of Twins Reared Apart.

Authors:  T J Bouchard; D T Lykken; M McGue; N L Segal; A Tellegen
Journal:  Science       Date:  1990-10-12       Impact factor: 47.728

8.  Long lasting effects of LSD on normals.

Authors:  W McGlothlin; S Cohen; M S McGlothlin
Journal:  Arch Gen Psychiatry       Date:  1967-11

9.  Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies.

Authors:  Erich Studerus; Michael Kometer; Felix Hasler; Franz X Vollenweider
Journal:  J Psychopharmacol       Date:  2010-09-20       Impact factor: 4.153

10.  Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents.

Authors:  R A Glennon; M Titeler; J D McKenney
Journal:  Life Sci       Date:  1984-12-17       Impact factor: 5.037

View more
  145 in total

Review 1.  Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model.

Authors:  Clint E Canal; Drake Morgan
Journal:  Drug Test Anal       Date:  2012-04-19       Impact factor: 3.345

2.  Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin.

Authors:  Frederick S Barrett; Matthew W Johnson; Roland R Griffiths
Journal:  J Psychopharmacol       Date:  2015-10-06       Impact factor: 4.153

3.  LSD enhances the emotional response to music.

Authors:  M Kaelen; F S Barrett; L Roseman; R Lorenz; N Family; M Bolstridge; H V Curran; A Feilding; D J Nutt; R L Carhart-Harris
Journal:  Psychopharmacology (Berl)       Date:  2015-08-11       Impact factor: 4.530

Review 4.  REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics.

Authors:  R L Carhart-Harris; K J Friston
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

Review 5.  Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.

Authors:  Rafael G Dos Santos; Flávia L Osório; José Alexandre S Crippa; Jordi Riba; Antônio W Zuardi; Jaime E C Hallak
Journal:  Ther Adv Psychopharmacol       Date:  2016-03-18

6.  Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin.

Authors:  Alexander V Lebedev; Martin Lövdén; Gidon Rosenthal; Amanda Feilding; David J Nutt; Robin L Carhart-Harris
Journal:  Hum Brain Mapp       Date:  2015-05-22       Impact factor: 5.038

7.  Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences.

Authors:  Theresa M Carbonaro; Matthew P Bradstreet; Frederick S Barrett; Katherine A MacLean; Robert Jesse; Matthew W Johnson; Roland R Griffiths
Journal:  J Psychopharmacol       Date:  2016-08-30       Impact factor: 4.153

8.  Individual differences in aesthetic engagement are reflected in resting-state fMRI connectivity: Implications for stress resilience.

Authors:  Paula G Williams; Kimberley T Johnson; Brian J Curtis; Jace B King; Jeffrey S Anderson
Journal:  Neuroimage       Date:  2018-06-17       Impact factor: 6.556

9.  A Five-Factor Theory Perspective on Causal Analysis.

Authors:  Robert R McCrae; Angelina R Sutin
Journal:  Eur J Pers       Date:  2018-01-15

10.  Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes.

Authors:  Bruce E Blough; Antonio Landavazo; Ann M Decker; John S Partilla; Michael H Baumann; Richard B Rothman
Journal:  Psychopharmacology (Berl)       Date:  2014-05-07       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.